生物通22 天
《Science Translational Medicine》新型双特异性抗体：对抗新冠变异毒株的 ...
为应对 SARS-CoV-2 变异株对抗体疗法的挑战，研究人员开发 NTD-RBD 双特异性抗体，其体外中和效果良好且有体内预防潜力。他们的研究成果发表在《Science Translational Medicine》上，为抗击新冠疫情带来了新的希望。 在 2019 年，新冠病毒（SARS-CoV-2）突然出现，引发了 ...
来自MSN10 个月
Novel bispecific antibodies show promise against evolving SARS-CoV-2 variants
In a recent research paper uploaded to the bioRxiv preprint* server, researchers developed and tested novel bispecific antibodies (bsAbs) comprising both the N-terminal domain (NTD) and the ...